Seizure burden and healthcare resource utilization among people living with drug-resistant focal epilepsy in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Seizure burden and healthcare resource utilization among people living with drug-resistant focal epilepsy in the United States

Published:2024-09-02 Issue: Volume: Page:1-10
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Mao Jianbin¹,Song Yan²,Cheng Mu²,Xu Churong²,Boca Andra²,Dandurand Ann¹,Takahashi Koji¹

Affiliation:

1. Cerevel Therapeutics, Cambridge, MA, USA

2. Analysis Group Inc., Boston, MA, USA

Funder

Cerevel Therapeutics

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2396049

Reference46 articles.

1. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. National and State Estimates of the Numbers of Adults and Children with Active Epilepsy — United States, 2015

3. Correction to: The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond

4. Treatment Patterns Of Antiepileptic Drugs In Patients With Potential Refractory Epilepsy In The Texas Medicaid Program

5. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP